Delivery Order SPE2DB25D3201-SPE2DB25FNSRF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units at a firm fixed price of $2,213.75. The contract carries an ultimate completion date of July 17, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.86 to AmerisourceBergen Drug Corp for 500 tablets of Risperidone 0.25 mg. This contract, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, is a firm fixed price delivery order with no set-aside designation. The award reflects a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,169.30 by the Defense Logistics Agency on May 29, 2025, for the supply of Risperidone 0.5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of May 30, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's ability to meet federal procurement requirements...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,029.30 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Risperidone 3 mg tablets in quantities of 60 units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is expected to be completed by August 18, 2025, with performance taking place at the vendor's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on June 18, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units. This firm fixed-price contract, valued at $2,656.71, represents a non-competitive, non-set-aside award with an ultimate completion date of June 20, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Risperidone 2 mg, valued at $3,385.90. This firm fixed-price, non-set-aside contract was executed on June 18, 2025, with an ultimate completion date of June 20, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperidone 0.5 mg tablets in a 60-count quantity, with a ceiling value of $1,310.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,275.84 to AmerisourceBergen Drug Corp for Risperidone 3 mg tablets (60-count units) on September 4, 2025, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and represents a routine pharmaceutical supply transaction for federal medical operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.16 to AmerisourceBergen Drug Corp for the supply of Risperdal (risperidone) 2 mg tablets in a 60-count package. This competitively awarded, non-set-aside firm fixed price delivery order was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNSRFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,054.47 to AmerisourceBergen Drug Corp for the supply of Risperidone 2 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, leverages this framework contract to deliver essential medications including specialty drugs, generics, vaccines, and related medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/24/25 |